Literature DB >> 21367666

Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors.

María Salgado1, Norma I Rallón, Berta Rodés, Mariola López, Vincent Soriano, José Miguel Benito.   

Abstract

Interleukin 17 (IL17) secreting T (Th17) cells play a protective role against bacterial infections at mucosal surfaces. Recent reports show Th17 cells are depleted in the gut associated lymphoid tissue of HIV+ patients, but their role in HIV disease progression is not well understood. Expression of the IL17 receptor (IL17R) and the production of IL17 were compared between two groups of HIV patients with different disease progression (long-term-nonprogressors, LTNP and typical-progressors, TP). IL17R expression was similar in LTNP and TP, whereas Th17 cell number was greater in LTNP than TP (p=0.015). An inverse correlation between the plasma HIV-RNA and both IL17R expression and Th17 cell number was found (p=0.001 and p=0.002, respectively). The increased number of Th17 cells in LTNP could lead to a more preserved immune response against bacterial infections. As a result, lower microbial translocation could explain the reduced immune activation and slower disease progression seen in LTNP.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367666     DOI: 10.1016/j.clim.2011.02.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  35 in total

1.  Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.

Authors:  Yongjun Jiang; Fangyuan Zhou; Yao Tian; Zining Zhang; Rongmei Kuang; Jing Liu; Xiaoxu Han; Qinghai Hu; Junjie Xu; Hong Shang
Journal:  J Clin Immunol       Date:  2013-09-03       Impact factor: 8.317

2.  IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.

Authors:  Jayashree Ravichandran; Ronald J Jackson; Shubhanshi Trivedi; Charani Ranasinghe
Journal:  J Interferon Cytokine Res       Date:  2014-12-10       Impact factor: 2.607

3.  Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Authors:  Valentina Cecchinato; Enos Bernasconi; Roberto F Speck; Michele Proietti; Ulrike Sauermann; Gianluca D'Agostino; Gabriela Danelon; Tanja Rezzonico Jost; Fabio Grassi; Lorenzo Raeli; Franziska Schöni-Affolter; Christiane Stahl-Hennig; Mariagrazia Uguccioni
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

4.  Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.

Authors:  Stephanie M Dillon; Jon Kibbie; Eric J Lee; Kejun Guo; Mario L Santiago; Gregory L Austin; Sara Gianella; Alan L Landay; Andrew M Donovan; Daniel N Frank; Martin D McCARTER; Cara C Wilson
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

5.  Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancers.

Authors:  Yang Wang; Xiaofan Lu; Hao Wu; Wei Li
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

6.  Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infection.

Authors:  F J Ibarrondo; S B Wilson; L E Hultin; R Shih; M A Hausner; P M Hultin; P A Anton; B D Jamieson; O O Yang
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

7.  HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli.

Authors:  Stephanie M Dillon; Jennifer A Manuzak; Amanda K Leone; Eric J Lee; Lisa M Rogers; Martin D McCarter; Cara C Wilson
Journal:  J Immunol       Date:  2012-06-11       Impact factor: 5.422

8.  Impact of early cART in the gut during acute HIV infection.

Authors:  Claire Deleage; Alexandra Schuetz; W Gregory Alvord; Leslie Johnston; Xing-Pei Hao; David R Morcock; Rungsun Rerknimitr; James L K Fletcher; Suwanna Puttamaswin; Nittaya Phanuphak; Robin Dewar; Joseph M McCune; Irini Sereti; Merlin Robb; Jerome H Kim; Timothy W Schacker; Peter Hunt; Jeffrey D Lifson; Jintanat Ananworanich; Jacob D Estes
Journal:  JCI Insight       Date:  2016-07-07

Review 9.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Authors:  Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.